藏醫(yī)藥治療子宮肌瘤的研究概況

【摘 要】 通過查閱、分析、歸納藏醫(yī)藥治療子宮肌瘤的相關(guān)文獻(xiàn)，從藏醫(yī)學(xué)理論的病因病機(jī)，藥物治療、聯(lián)合治療兩個(gè)方面對(duì)藏醫(yī)藥治療子宮肌瘤進(jìn)行綜述，總結(jié)其用藥和治療技法方面的特色，為臨床治療子宮肌瘤提供藏醫(yī)藥的診治思路及方法，并以此為基，就如何推廣民族醫(yī)藥以及如何彰顯民族醫(yī)藥治療子宮肌瘤的特色提出建議。

【關(guān)鍵詞】 藏醫(yī)藥;子宮肌瘤;研究概況

【中圖分類號(hào)】R29   【文獻(xiàn)標(biāo)志碼】 A    【文章編號(hào)】1007-8517（2022）16-0061-04

Research Overview on Treatment of Uterine Fibroids with Tibetan Medicine

ZHAO Chenxun DUAN Xiaohua CHEN Pu*

Yunnan University of Traditional Chinese Medicine，Yunnan Key Laboratory of Dai Medicine and Yi Medicine，Kunming 650500，China

Abstract：Through consulting， analysis， induction factors influencing the literature for the treatment of uterine fibroids， etiology and pathogenesis of Tibetan medicine theory and drug therapy， combination treatment two aspects of essential treatment of uterine fibroids were reviewed， summarized its characteristics and drug treatment techniques， and provide essential for clinical treatment of uterine fibroids of the thoughts and the methods of diagnosis and treatment， as the base， how to popularize ethnic medicine and how to highlight the characteristics of ethnic medicine in the treatment of uterine fibroids are put forward.

Key words：Traditional Tibetan Medicine; Myoma of Uterus; Research Overview

子宮肌瘤是由子宮平滑肌細(xì)胞異常增殖引起的，是女性最常見的良性腫瘤之一，也是子宮切除術(shù)的主要原因之一[1]，30～50歲育齡婦女是主要的疾病群。（剩余7236字）